基底动脉闭塞取栓联合或不联合静脉溶栓治疗
基于法国21中心前瞻性观察性登记研究,经倾向性评分匹配后比较基底动脉闭塞患者单纯血管内治疗与静脉溶栓联合血管内治疗,两组90天良好功能结局、功能独立及安全性结局均无显著差异,但受样本量和观察性设计限制,需进一步研究确认。
要点
- 匹配后单纯EVT组与IVT+EVT组90天良好功能结局(mRS 0-3)无显著差异(aOR 1.27,95%CI 0.68-2.37,p=0.45)。
- 两组90天功能独立(mRS 0-2)无显著差异(aOR 1.50,95%CI 0.79-2.85,p=0.21)。
- 症状性颅内出血和90天全因死亡率两组相似(aOR 0.42,95%CI 0.10-1.79,p=0.24;aOR 0.56,95%CI 0.29-1.10,p=0.09)。
核心结论
- 在该倾向性评分匹配分析中,单纯血管内治疗似乎与静脉溶栓联合血管内治疗达到相似的神经功能恢复,安全性特征相当。
- 鉴于本研究的样本量和观察性性质,需要进一步研究以确认这些发现。
研究设计与样本
- 研究分析法国21个中心2015年1月1日至2021年12月31日期间前瞻性、观察性、多中心缺血性卒中血管内治疗登记(Endovascular Treatment in Ischemic Stroke registry)数据。
- 纳入基底动脉闭塞和/或颅内椎动脉闭塞患者,经倾向性评分匹配后比较单纯血管内治疗组与静脉溶栓联合血管内治疗组。
- 倾向性评分纳入变量包括卒中前mRS、血脂异常、糖尿病、抗凝治疗、入院方式、基线NIHSS和ASPECTS、麻醉类型及症状发作至穿刺时间。
主要发现
- 共385例患者,倾向性评分匹配后纳入243例(单纯EVT组134例,IVT+EVT组109例)。
- 单纯EVT组与IVT+EVT组90天良好功能结局(mRS 0-3)无显著差异(aOR 1.27,95%CI 0.68-2.37,p=0.45)。
- 单纯EVT组与IVT+EVT组90天功能独立(mRS 0-2)无显著差异(aOR 1.50,95%CI 0.79-2.85,p=0.21)。
- 单纯EVT组与IVT+EVT组症状性颅内出血无显著差异(aOR 0.42,95%CI 0.10-1.79,p=0.24)。
- 单纯EVT组与IVT+EVT组90天全因死亡率无显著差异(aOR 0.56,95%CI 0.29-1.10,p=0.09)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文指出鉴于本研究的样本量,需要进一步研究以确认这些发现。
- 原文指出鉴于本研究的观察性性质,需要进一步研究以确认这些发现。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Two randomized trials demonstrated the benefit of endovascular therapy (EVT) in patients suffering from a stroke due to a basilar artery occlusion (BAO). However, intravenous thrombolytic (IVT) use before EVT was low in these trials, questioning the added value of this treatment in this setting. We sought to investigate the efficacy and safety of EVT alone compared to IVT + EVT in stroke patients with a BAO. METHODS: We analyzed data from the Endovascular Treatment in Ischemic Stroke registry, a prospective, observational, multicenter study of acute ischemic stroke patients treated with EVT in 21 centers in France between 1 January 2015 and 31 December 2021. We included patients with BAO and/or intracranial vertebral artery occlusion and compared patients treated with EVT alone versus IVT + EVT after propensity score (PS) matching. Variables selected for the PS were pre-stroke mRS, dyslipidemia, diabetes, anticoagulation, admission mode, baseline NIHSS and ASPECTS, type of anesthesia, and time from symptom onset to puncture. Efficacy outcomes were good functional outcome (modified Rankin Scale [mRS] 0-3) and functional independence (mRS 0-2) at 90 days. Safety outcomes were symptomatic intracranial hemorrhages and all-cause mortality at 90 days. RESULTS: Among 385 patients, 243 (134 EVT alone and 109 IVT + EVT) were included after PS matching. There was no difference between EVT alone and IVT + EVT regarding good functional outcome (adjusted odd ratio [aOR] labeling = 1.27, 95% confidence interval [CI], 0.68-2.37, p = 0.45) and functional independence (aOR = 1.50, 95% CI, 0.79-2.85, p = 0.21). Symptomatic intracranial hemorrhage and all-cause mortality were also similar between the two groups (aOR = 0.42, 95% CI, 0.10-1.79, p = 0.24 and aOR = 0.56, 95% CI, 0.29-1.10, p = 0.09, respectively). INTERPRETATION: In this PS matching analysis, EVT alone seemed to lead to similar neurological recovery than IVT + EVT, with comparable safety profile. However, given our sample size and the observational nature of this study, further studies are needed to confirm these findings. ANN NEUROL 2023;94:596-604.
引用
- Maïer B, Finitsis S, Mazighi M, et al. Thrombectomy with or without Intravenous Thrombolytics in Basilar Artery Occlusion. Ann Neurol. 2023. PMID: 37314741. doi:10.1002/ana.26720
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。